Discrepancies in Moderna’s FDA Report Demand Answers

Neither Moderna’s nor Pfizer’s studies leading to filing for the Emergency Use Authorization have addressed long-term safety.

Moderna’s reported death rate for its COVID vaccine, based on clinical trials, is 5.41 times greater than Pfizer’s. Yet neither are representative of national death rates — that’s a red flag.